ubt251 vs retatrutide at 24 week. • UBT251: up to 19.7% mean weight loss • Retatrutide: up to 17.5% Both are triple agonists targeting GLP-1, GIP & glucagon. Early Phase 2 data amble retatrutide Retatrutide Triple Agonist

Estimated reading time: 7 minutes Retatrutide has quickly become one of the most talked-about medications in obesity medicine, and it isnt even approved by the U.S

Wegovy

The medication typically lowers blood pressure as a secondary benefit, especially when weight loss occurs

It works by reducing appetite, slowing stomach emptying, and affecting hormones that regulate metabolism and body weight

Glutathione (GSH) maintains a reduced cellular environment and is widely believed to mitigate disease-associated oxidative damage to proteins, thereby protecting against metabolic dysfunctionassociated steatotic liver disease (MASLD)